United States · FDA National Drug Code directory

JANUVIA

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0006-0277_71d449de-955b-4711-9a44-1e1f66e2e9eb
Product NDC
0006-0277
Form
TABLET, FILM COATED
Composition / generic term
sitagliptin
Labeler
Merck Sharp & Dohme LLC
Marketing category
NDA
Marketing start / end (source format)
20061016
Source listing expiry
20261231

Source-listed ingredients

  • SITAGLIPTIN PHOSPHATE — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, FILM COATED in 1 DOSE PACK (0006-0277-02) · 0006-0277-02
  • 2 BLISTER PACK in 1 CARTON (0006-0277-14) / 7 TABLET, FILM COATED in 1 BLISTER PACK · 0006-0277-14
  • 100 BLISTER PACK in 1 CARTON (0006-0277-28) / 1 TABLET, FILM COATED in 1 BLISTER PACK (0006-0277-01) · 0006-0277-28
  • 30 TABLET, FILM COATED in 1 BOTTLE (0006-0277-31) · 0006-0277-31
  • 30 TABLET, FILM COATED in 1 DOSE PACK (0006-0277-33) · 0006-0277-33
  • 90 TABLET, FILM COATED in 1 BOTTLE (0006-0277-54) · 0006-0277-54
  • 1000 TABLET, FILM COATED in 1 BOTTLE (0006-0277-82) · 0006-0277-82

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →